Loading...
Header Logo
Keywords
Last Name
Institution

Dr Piero Olliaro

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Olliaro PL, Merle C, Mthiyane T, Bah B, Kassa F, Amukoye E, N Diaye A, Perronne C, Lienhardt C, McIlleron H, Fielding K. Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2017 07; 61(7). PMID: 28438924.
      View in: PubMed
    2. Zwang J, D'Alessandro U, Ndiaye JL, Djimdé AA, Dorsey G, Mårtensson AA, Karema C, Olliaro PL. Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa. BMC Infect Dis. 2017 06 23; 17(1):443. PMID: 28645255.
      View in: PubMed
    3. Zwang J, Olliaro P. Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis. Parasit Vectors. 2017 01 26; 10(1):47. PMID: 28126024.
      View in: PubMed
    4. Olliaro PL, Barnwell JW, Barry A, Mendis K, Mueller I, Reeder JC, Shanks GD, Snounou G, Wongsrichanalai C. Implications of Plasmodium vivax Biology for Control, Elimination, and Research. Am J Trop Med Hyg. 2016 Dec 28; 95(6 Suppl):4-14. PMID: 27799636.
      View in: PubMed
    5. Walker M, Mabud TS, Olliaro PL, Coulibaly JT, King CH, Raso G, Scherrer AU, Stothard JR, Sousa-Figueiredo JC, Stete K, Utzinger J, Basáñez MG. New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel. Parasit Vectors. 2016 Jan 27; 9:41. PMID: 26813154.
      View in: PubMed
    6. Medley GF, Hollingsworth TD, Olliaro PL, Adams ER. Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent. Nature. 2015 Dec 03; 528(7580):S102-8. PMID: 26633763.
      View in: PubMed
    7. Nguyen TD, Olliaro P, Dondorp AM, Baird JK, Lam HM, Farrar J, Thwaites GE, White NJ, Boni MF. Optimum population-level use of artemisinin combination therapies: a modelling study. Lancet Glob Health. 2015 Dec; 3(12):e758-66. PMID: 26545449.
      View in: PubMed
    8. Horby PW, Endzt H, Endtz H, Muyembe-Tamfum JJ, van Griensven J, Gevao S, Goossens H, Malvy D, Malvy JM, Haba NY, Yazdanpanah Y, Olliaro P, Semple C, de Jong M, Delamou A, Lang T, Carson G, Kennedy SB, Kennedy S. Ebola: Europe-Africa research collaborations. Lancet Infect Dis. 2015 Nov; 15(11):1258-9. PMID: 26531029.
      View in: PubMed
    9. Olliaro PL, Vaillant M, Diawara A, Coulibaly JT, Garba A, Keiser J, King CH, Knopp S, Landouré A, N'Goran EK, Raso G, Scherrer AU, Sousa-Figueiredo JC, Stete K, Zhou XN, Utzinger J. Toward Measuring Schistosoma Response to Praziquantel Treatment with Appropriate Descriptors of Egg Excretion. PLoS Negl Trop Dis. 2015; 9(6):e0003821. PMID: 26086551.
      View in: PubMed
    10. Ejo M, Gehre F, Barry MD, Sow O, Bah NM, Camara M, Bah B, Uwizeye C, Nduwamahoro E, Fissette K, De Rijk P, Merle C, Olliaro P, Burgos M, Lienhardt C, Rigouts L, de Jong BC. First insights into circulating Mycobacterium tuberculosis complex lineages and drug resistance in Guinea. Infect Genet Evol. 2015 Jul; 33:314-9. PMID: 26004194.
      View in: PubMed
    11. Faust C, Zelner J, Brasseur P, Vaillant M, Badiane M, Cisse M, Grenfell B, Olliaro P. Assessing drivers of full adoption of test and treat policy for malaria in Senegal. Am J Trop Med Hyg. 2015 Jul; 93(1):159-167. PMID: 25962776.
      View in: PubMed
    12. Heymann DL, Chen L, Takemi K, Fidler DP, Tappero JW, Thomas MJ, Kenyon TA, Frieden TR, Yach D, Nishtar S, Kalache A, Olliaro PL, Horby P, Torreele E, Gostin LO, Ndomondo-Sigonda M, Carpenter D, Rushton S, Lillywhite L, Devkota B, Koser K, Yates R, Dhillon RS, Rannan-Eliya RP. Global health security: the wider lessons from the west African Ebola virus disease epidemic. Lancet. 2015 May 09; 385(9980):1884-901. PMID: 25987157.
      View in: PubMed
    13. Parapini S, Olliaro P, Navaratnam V, Taramelli D, Basilico N. Stability of the antimalarial drug dihydroartemisinin under physiologically relevant conditions: implications for clinical treatment and pharmacokinetic and in vitro assays. Antimicrob Agents Chemother. 2015 Jul; 59(7):4046-52. PMID: 25918150.
      View in: PubMed
    14. Cooper BS, Boni MF, Pan-ngum W, Day NP, Horby PW, Olliaro P, Lang T, White NJ, White LJ, Whitehead J. Evaluating clinical trial designs for investigational treatments of Ebola virus disease. PLoS Med. 2015 Apr; 12(4):e1001815. PMID: 25874579.
      View in: PubMed
    15. Olliaro PL, Kuesel AC, Reeder JC. A changing model for developing health products for poverty-related infectious diseases. PLoS Negl Trop Dis. 2015 Jan; 9(1):e3379. PMID: 25569161.
      View in: PubMed
    16. Abba K, Kirkham AJ, Olliaro PL, Deeks JJ, Donegan S, Garner P, Takwoingi Y. Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries. Cochrane Database Syst Rev. 2014 Dec 18; (12):CD011431. PMID: 25519857.
      View in: PubMed
    17. Olliaro P, Lasry E, Tiffany A. Out of (west) Africa-who lost in the end? Am J Trop Med Hyg. 2015 Feb; 92(2):242-243. PMID: 25510720.
      View in: PubMed
    18. Nasser SM, Cooke G, Kranzer K, Norris SL, Olliaro P, Ford N. Strength of recommendations in WHO guidelines using GRADE was associated with uptake in national policy. J Clin Epidemiol. 2015 Jun; 68(6):703-7. PMID: 25578218.
      View in: PubMed
    19. Gehre F, Ejo M, Fissette K, de Rijk P, Uwizeye C, Nduwamahoro E, Goovaerts O, Affolabi D, Gninafon M, Lingoupou FM, Barry MD, Sow O, Merle C, Olliaro P, Ba F, Sarr M, Piubello A, Noeske J, Antonio M, Rigouts L, de Jong BC. Shifts in Mycobacterial Populations and Emerging Drug-Resistance in West and Central Africa. PLoS One. 2014; 9(12):e110393. PMID: 25493429.
      View in: PubMed
    20. Matlashewski G, Arana B, Kroeger A, Be-Nazir A, Mondal D, Nabi SG, Banjara MR, Das ML, Marasini B, Das P, Medley G, Satoskar A, Nakhasi H, Argaw D, Reeder J, Olliaro P. Research priorities for elimination of visceral leishmaniasis. Lancet Glob Health. 2014 Dec; 2(12):e683-4. PMID: 25433617.
      View in: PubMed
    21. Zwang J, Olliaro PL. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials. PLoS Negl Trop Dis. 2014; 8(11):e3286. PMID: 25412105.
      View in: PubMed
    22. Zaloumis SG, Tarning J, Krishna S, Price RN, White NJ, Davis TM, McCaw JM, Olliaro P, Maude RJ, Kremsner P, Dondorp A, Gomes M, Barnes K, Simpson JA. Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria. CPT Pharmacometrics Syst Pharmacol. 2014 Nov 05; 3:e145. PMID: 25372510.
      View in: PubMed
    23. Reuter SE, Upton RN, Evans AM, Navaratnam V, Olliaro PL. Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria. J Antimicrob Chemother. 2015 Mar; 70(3):868-76. PMID: 25377567.
      View in: PubMed
    24. Merle CS, Fielding K, Sow OB, Gninafon M, Lo MB, Mthiyane T, Odhiambo J, Amukoye E, Bah B, Kassa F, N'Diaye A, Rustomjee R, de Jong BC, Horton J, Perronne C, Sismanidis C, Lapujade O, Olliaro PL, Lienhardt C. A four-month gatifloxacin-containing regimen for treating tuberculosis. N Engl J Med. 2014 Oct 23; 371(17):1588-98. PMID: 25337748.
      View in: PubMed
    25. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, Vazquez S, Cartozian E, Pelegrino JL, Artsob H, Guzman MG, Olliaro P, Zwang J, Guillerm M, Kliks S, Halstead S, Peeling RW, Margolis HS. Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody. PLoS Negl Trop Dis. 2014 Oct; 8(10):e3171. PMID: 25330157.
      View in: PubMed
    26. Adebamowo C, Bah-Sow O, Binka F, Bruzzone R, Caplan A, Delfraissy JF, Heymann D, Horby P, Kaleebu P, Tamfum JJ, Olliaro P, Piot P, Tejan-Cole A, Tomori O, Toure A, Torreele E, Whitehead J. Randomised controlled trials for Ebola: practical and ethical issues. Lancet. 2014 Oct 18; 384(9952):1423-4. PMID: 25390318.
      View in: PubMed
    27. Kramer CV, Zhang F, Sinclair D, Olliaro PL. Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev. 2014 Aug 06; (8):CD000053. PMID: 25099517.
      View in: PubMed
    28. Ouattara AF, Dagnogo M, Olliaro PL, Raso G, Tanner M, Utzinger J, Koudou BG. Plasmodium falciparum infection and clinical indicators in relation to net coverage in central Côte d'Ivoire. Parasit Vectors. 2014 Jul 03; 7:306. PMID: 24990595.
      View in: PubMed
    29. Gaubert A, Kauss T, Marchivie M, Ba BB, Lembege M, Fawaz F, Boiron JM, Lafarge X, Lindegardh N, Fabre JL, White NJ, Olliaro PL, Millet P, Grislain L, Gaudin K. Preliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas. Int J Pharm. 2014 Jul 01; 468(1-2):55-63. PMID: 24726300.
      View in: PubMed
    30. Zwang J, Dorsey G, Mårtensson A, d'Alessandro U, Ndiaye JL, Karema C, Djimde A, Brasseur P, Sirima SB, Olliaro P. Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009. Malar J. 2014 Mar 25; 13:114. PMID: 24666562.
      View in: PubMed
    31. Ouattara AF, Dagnogo M, Constant EA, Koné M, Raso G, Tanner M, Olliaro PL, Utzinger J, Koudou BG. Transmission of malaria in relation to distribution and coverage of long-lasting insecticidal nets in central Côte d'Ivoire. Malar J. 2014 Mar 19; 13:109. PMID: 24645751.
      View in: PubMed
    32. Vermeersch A, Libaud-Moal A, Rodrigues A, White NJ, Olliaro P, Gomes M, Ashley EA, Millet P. Introducing the concept of a new pre-referral treatment for severely ill febrile children at community level: a sociological approach in Guinea-Bissau. Malar J. 2014 Feb 06; 13:50. PMID: 24502695.
      View in: PubMed
    33. Zani B, Gathu M, Donegan S, Olliaro PL, Sinclair D. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst Rev. 2014 Jan 20; (1):CD010927. PMID: 24443033.
      View in: PubMed
    34. Olliaro P, Delgado-Romero P, Keiser J. The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer). J Antimicrob Chemother. 2014 Apr; 69(4):863-70. PMID: 24390933.
      View in: PubMed
    35. Dunning JW, Merson L, Rohde GGU, Gao Z, Semple MG, Tran D, Gordon A, Olliaro PL, Khoo SH, Bruzzone R, Horby P, Cobb JP, Longuere KS, Kellam P, Nichol A, Brett S, Everett D, Walsh TS, Hien TT, Yu H, Zambon M, Ruiz-Palacios G, Lang T, Akhvlediani T. Open source clinical science for emerging infections. Lancet Infect Dis. 2014 Jan; 14(1):8-9. PMID: 24355025.
      View in: PubMed
    36. Gogtay N, Kannan S, Thatte UM, Olliaro PL, Sinclair D. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria. Cochrane Database Syst Rev. 2013 Oct 25; (10):CD008492. PMID: 24163021.
      View in: PubMed
    37. Pedrique B, Strub-Wourgaft N, Some C, Olliaro P, Trouiller P, Ford N, Pécoul B, Bradol JH. The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment. Lancet Glob Health. 2013 Dec; 1(6):e371-9. PMID: 25104602.
      View in: PubMed
    38. Olliaro PL, Vaillant M, Hayes DJ, Montresor A, Chitsulo L. Practical dosing of praziquantel for schistosomiasis in preschool-aged children. Trop Med Int Health. 2013 Sep; 18(9):1085-1089. PMID: 23937700.
      View in: PubMed
    39. Robertson MN, Ylioja PM, Williamson AE, Woelfle M, Robins M, Badiola KA, Willis P, Olliaro P, Wells TN, Todd MH. Open source drug discovery - a limited tutorial. Parasitology. 2014 Jan; 141(1):148-57. PMID: 23985301.
      View in: PubMed
    40. Staehli Hodel EM, Guidi M, Zanolari B, Mercier T, Duong S, Kabanywanyi AM, Ariey F, Buclin T, Beck HP, Decosterd LA, Olliaro P, Genton B, Csajka C. Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients. Malar J. 2013 Jul 10; 12:235. PMID: 23841950.
      View in: PubMed
    41. Dellicour S, Brasseur P, Thorn P, Gaye O, Olliaro P, Badiane M, Stergachis A, ter Kuile FO. Probabilistic record linkage for monitoring the safety of artemisinin-based combination therapy in the first trimester of pregnancy in Senegal. Drug Saf. 2013 Jul; 36(7):505-13. PMID: 23673815.
      View in: PubMed
    42. Smythe W, Merle CS, Rustomjee R, Gninafon M, Lo MB, Bah-Sow O, Olliaro PL, Lienhardt C, Horton J, Smith P, McIlleron H, Simonsson US. Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using monte carlo simulations. Antimicrob Agents Chemother. 2013 Sep; 57(9):4164-71. PMID: 23774436.
      View in: PubMed
    43. Olliaro P, Vaillant M, Arana B, Grogl M, Modabber F, Magill A, Lapujade O, Buffet P, Alvar J. Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis. PLoS Negl Trop Dis. 2013; 7(3):e2130. PMID: 23556016.
      View in: PubMed
    44. Danso-Appiah A, Olliaro PL, Donegan S, Sinclair D, Utzinger J. Drugs for treating Schistosoma mansoni infection. Cochrane Database Syst Rev. 2013 Feb 28; (2):CD000528. PMID: 23450530.
      View in: PubMed
    45. Staehli Hodel EM, Csajka C, Ariey F, Guidi M, Kabanywanyi AM, Duong S, Decosterd LA, Olliaro P, Beck HP, Genton B. Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania. Antimicrob Agents Chemother. 2013 Feb; 57(2):950-8. PMID: 23229480.
      View in: PubMed
    46. Brasseur P, Vaillant MT, Olliaro PL. Anti-malarial drug safety information obtained through routine monitoring in a rural district of South-Western Senegal. Malar J. 2012 Dec 05; 11:402. PMID: 23216982.
      View in: PubMed
    47. Kauss T, Gaubert A, Boyer C, Ba BB, Manse M, Massip S, Léger JM, Fawaz F, Lembege M, Boiron JM, Lafarge X, Lindegardh N, White NJ, Olliaro P, Millet P, Gaudin K. Pharmaceutical development and optimization of azithromycin suppository for paediatric use. Int J Pharm. 2013 Jan 30; 441(1-2):218-26. PMID: 23220079.
      View in: PubMed
    48. Zwang J, Dorsey G, Djimdé A, Karema C, Mårtensson A, Ndiaye JL, Sirima SB, Olliaro P. Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa. Malar J. 2012 Aug 02; 11:260. PMID: 22856598.
      View in: PubMed
    49. Kauss T, Gaudin K, Gaubert A, Ba B, Tagliaferri S, Fawaz F, Fabre JL, Boiron JM, Lafarge X, White NJ, Olliaro PL, Millet P. Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment. Int J Pharm. 2012 Oct 15; 436(1-2):624-30. PMID: 22868232.
      View in: PubMed
    50. Finaurini S, Basilico N, Corbett Y, D'Alessandro S, Parapini S, Olliaro P, Haynes RK, Taramelli D. Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle. Toxicology. 2012 Oct 09; 300(1-2):57-66. PMID: 22677887.
      View in: PubMed
    51. Young T, Abba K, Deeks JJ, Olliaro PL, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P, Bottieau E, Jacobs J, Nachega JB, Leeflang M. Cochrane Column * Rapid diagnostic tests can extend access of diagnostic services for uncomplicated Plasmodium falciparum malaria * Commentary: Rapid diagnostic tests for diagnosing uncomplicated Plasmodium falciparum malaria in endemic countries (Review) * Approach to conducting Cochrane Diagnostic Test Accuracy Reviews. Int J Epidemiol. 2012 Jun; 41(3):607-10. PMID: 22798691.
      View in: PubMed
    52. Olliaro P, Vaillant MT, Sundar S, Balasegaram M. More efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effects. PLoS Negl Trop Dis. 2012; 6(5):e1545. PMID: 22666508.
      View in: PubMed
    53. Merle CS, Sismanidis C, Sow OB, Gninafon M, Horton J, Lapujade O, Lo MB, Mitchinson DA, Perronne C, Portaels F, Odhiambo J, Olliaro P, Rustomjee R, Lienhardt C, Fielding K. A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project. Trials. 2012 May 18; 13:61. PMID: 22607233.
      View in: PubMed
    54. Boyer C, Gaudin K, Kauss T, Gaubert A, Boudis A, Verschelden J, Franc M, Roussille J, Boucher J, Olliaro P, White NJ, Millet P, Dubost JP. Development of NIRS method for quality control of drug combination artesunate-azithromycin for the treatment of severe malaria. J Pharm Biomed Anal. 2012 Aug-Sep; 67-68:10-5. PMID: 22579599.
      View in: PubMed
    55. Zwang J, Ndiaye JL, Djimdé A, Dorsey G, Mårtensson A, Karema C, Olliaro P. Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa. Malar J. 2012 Jan 25; 11:25. PMID: 22276858.
      View in: PubMed
    56. Smythe W, Khandelwal A, Merle C, Rustomjee R, Gninafon M, Bocar Lo M, Sow OB, Olliaro PL, Lienhardt C, Horton J, Smith P, McIlleron H, Simonsson US. A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patients. Antimicrob Agents Chemother. 2012 Apr; 56(4):2091-8. PMID: 22252827.
      View in: PubMed
    57. Effa EE, Lassi ZS, Critchley JA, Garner P, Sinclair D, Olliaro PL, Bhutta ZA. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2011 Oct 05; (10):CD004530. PMID: 21975746.
      View in: PubMed
    58. Croft SL, Olliaro P. Leishmaniasis chemotherapy--challenges and opportunities. Clin Microbiol Infect. 2011 Oct; 17(10):1478-83. PMID: 21933306.
      View in: PubMed
    59. Olliaro P, Djimdé A, Dorsey G, Karema C, Mårtensson A, Ndiaye JL, Sirima SB, Vaillant M, Zwang J. Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Am J Trop Med Hyg. 2011 Oct; 85(4):619-25. PMID: 21976561.
      View in: PubMed
    60. Woelfle M, Olliaro P, Todd MH. Open science is a research accelerator. Nat Chem. 2011 Sep 23; 3(10):745-8. PMID: 21941234.
      View in: PubMed
    61. Woelfle M, Seerden JP, de Gooijer J, Pouwer K, Olliaro P, Todd MH. Resolution of praziquantel. PLoS Negl Trop Dis. 2011 Sep; 5(9):e1260. PMID: 21949890.
      View in: PubMed
    62. Brasseur P, Badiane M, Cisse M, Agnamey P, Vaillant MT, Olliaro PL. Changing patterns of malaria during 1996-2010 in an area of moderate transmission in southern Senegal. Malar J. 2011 Jul 25; 10:203. PMID: 21787420.
      View in: PubMed
    63. Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, Donegan S, Garner P. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev. 2011 Jul 06; (7):CD008122. PMID: 21735422.
      View in: PubMed
    64. Sinclair D, Gogtay N, Brand F, Olliaro P. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria. Cochrane Database Syst Rev. 2011 Jul 06; (7):CD008492. PMID: 21735431.
      View in: PubMed
    65. Olliaro PL, Vaillant MT, Belizario VJ, Lwambo NJ, Ouldabdallahi M, Pieri OS, Amarillo ML, Kaatano GM, Diaw M, Domingues AC, Favre TC, Lapujade O, Alves F, Chitsulo L. A multicentre randomized controlled trial of the efficacy and safety of single-dose praziquantel at 40 mg/kg vs. 60 mg/kg for treating intestinal schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil. PLoS Negl Trop Dis. 2011 Jun; 5(6):e1165. PMID: 21695161.
      View in: PubMed
    66. D'Alessandro S, Basilico N, Corbett Y, Scaccabarozzi D, Omodeo-Salè F, Saresella M, Marventano I, Vaillant M, Olliaro P, Taramelli D. Hypoxia modulates the effect of dihydroartemisinin on endothelial cells. Biochem Pharmacol. 2011 Sep 01; 82(5):476-84. PMID: 21684264.
      View in: PubMed
    67. Olliaro P, Seiler J, Kuesel A, Horton J, Clark JN, Don R, Keiser J. Potential drug development candidates for human soil-transmitted helminthiases. PLoS Negl Trop Dis. 2011 Jun; 5(6):e1138. PMID: 21695247.
      View in: PubMed
    68. Lacaze C, Kauss T, Kiechel JR, Caminiti A, Fawaz F, Terrassin L, Cuart S, Grislain L, Navaratnam V, Ghezzoul B, Gaudin K, White NJ, Olliaro PL, Millet P. The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership. Malar J. 2011 May 23; 10:142. PMID: 21605361.
      View in: PubMed
    69. Harhay MO, Olliaro PL, Costa DL, Costa CH. Urban parasitology: visceral leishmaniasis in Brazil. Trends Parasitol. 2011 Sep; 27(9):403-9. PMID: 21596622.
      View in: PubMed
    70. Mwingira F, Nkwengulila G, Schoepflin S, Sumari D, Beck HP, Snounou G, Felger I, Olliaro P, Mugittu K. Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa. Malar J. 2011 Apr 06; 10:79. PMID: 21470428.
      View in: PubMed
    71. Harhay MO, Olliaro PL, Vaillant M, Chappuis F, Lima MA, Ritmeijer K, Costa CH, Costa DL, Rijal S, Sundar S, Balasegaram M. Who is a typical patient with visceral leishmaniasis? Characterizing the demographic and nutritional profile of patients in Brazil, East Africa, and South Asia. Am J Trop Med Hyg. 2011 Apr; 84(4):543-50. PMID: 21460007.
      View in: PubMed
    72. Olliaro P, Djimdé A, Karema C, Mårtensson A, Ndiaye JL, Sirima SB, Dorsey G, Zwang J. Standardised versus actual white cell counts in estimating thick film parasitaemia in African children under five. Trop Med Int Health. 2011 May; 16(5):551-4. PMID: 21395926.
      View in: PubMed
    73. Heemskerk D, Day J, Chau TT, Dung NH, Yen NT, Bang ND, Merson L, Olliaro P, Pouplin T, Caws M, Wolbers M, Farrar J. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial. Trials. 2011 Feb 02; 12:25. PMID: 21288325.
      View in: PubMed
    74. Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K, Kumari P, Lal CS, Arora R, Sharma B, Ellis S, Strub-Wourgaft N, Balasegaram M, Olliaro P, Das P, Modabber F. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet. 2011 Feb 05; 377(9764):477-86. PMID: 21255828.
      View in: PubMed
    75. Krudsood S, Looareesuwan S, Wilairatama P, Leowattana W, Tangpukdee N, Chalermrut K, Ramanathan S, Navaratnam V, Olliaro P, Vaillant M, Kiechel JR, Taylor WR. Effect of artesunate and mefloquine in combination on the Fridericia corrected QT intervals in Plasmodium falciparum infected adults from Thailand. Trop Med Int Health. 2011 Apr; 16(4):458-65. PMID: 21219551.
      View in: PubMed
    76. Harhay MO, Horton J, Olliaro PL, Utzinger J. Diagnostics are central for a truly holistic approach against intestinal parasitic diseases. Int J Infect Dis. 2011 Feb; 15(2):e76-7. PMID: 21145770.
      View in: PubMed
    77. Tine RC, Faye B, Ndiaye JL, Ndour CT, Brasseur P, Olliaro P, Gaye O. [Concomitant infection by Plasmodium falciparum and Schistosoma haematobium among school children in a rural area of Senegal]. Med Mal Infect. 2011 Feb; 41(2):112-4. PMID: 21129869.
      View in: PubMed
    78. Olliaro PL. Drug combinations for visceral leishmaniasis. Curr Opin Infect Dis. 2010 Dec; 23(6):595-602. PMID: 20871400.
      View in: PubMed
    79. Olliaro P, Vaillant MT. Alternative visual displays of metaanalysis of malaria treatment trials to facilitate translation of research into policy. Diagn Microbiol Infect Dis. 2010 Dec; 68(4):422-31. PMID: 21094426.
      View in: PubMed
    80. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol. 2010 12; 8(12 Suppl):S17-29. PMID: 21548184.
      View in: PubMed
    81. Hodel EM, Genton B, Zanolari B, Mercier T, Duong S, Beck HP, Olliaro P, Decosterd LA, Ariey F. Residual antimalarial concentrations before treatment in patients with malaria from Cambodia: indication of drug pressure. J Infect Dis. 2010 Oct 01; 202(7):1088-94. PMID: 20726764.
      View in: PubMed
    82. Meheus F, Balasegaram M, Olliaro P, Sundar S, Rijal S, Faiz MA, Boelaert M. Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl Trop Dis. 2010 Sep 07; 4(9). PMID: 20838649.
      View in: PubMed
    83. Kauss T, Fawaz F, Guyot M, Lagueny AM, Dos Santos I, Bonini F, Olliaro P, Caminiti A, Millet P. Fixed artesunate-amodiaquine combined pre-formulation study for the treatment of malaria. Int J Pharm. 2010 Aug 16; 395(1-2):198-204. PMID: 20635516.
      View in: PubMed
    84. Krudsood S, Looareesuwan S, Tangpukdee N, Wilairatana P, Phumratanaprapin W, Leowattana W, Chalermrut K, Ramanathan S, Navaratnam V, Olliaro P, Vaillant M, Kiechel JR, Taylor WR. New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine. Antimicrob Agents Chemother. 2010 Sep; 54(9):3730-7. PMID: 20547795.
      View in: PubMed
    85. Kauss T, Fawaz F, Guyot M, Lagueny AM, Dos Santos I, Bonini F, Olliaro P, Caminiti A, Millet P. Fixed artesunate-amodiaquine combined pre-formulation study for the treatment of malaria. Int J Pharm. 2010 Jun 01. PMID: 20685236.
      View in: PubMed
    86. Khatun F, Faruque AS, Koeck JL, Olliaro P, Millet P, Paris N, Malek MA, Salam MA, Luby S. Changing species distribution and antimicrobial susceptibility pattern of Shigella over a 29-year period (1980-2008). Epidemiol Infect. 2011 Mar; 139(3):446-52. PMID: 20478088.
      View in: PubMed
    87. Basilico N, Parapini S, Sisto F, Omodeo-Salè F, Coghi P, Ravagnani F, Olliaro P, Taramelli D. The lipid moiety of haemozoin (Malaria Pigment) and P. falciparum parasitised red blood cells bind synthetic and native endothelin-1. J Biomed Biotechnol. 2010; 2010:854927. PMID: 20204072.
      View in: PubMed
    88. Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis. 2010 Feb 15; 201(4):570-9. PMID: 20085495.
      View in: PubMed
    89. Harhay MO, Horton J, Olliaro PL. Epidemiology and control of human gastrointestinal parasites in children. Expert Rev Anti Infect Ther. 2010 Feb; 8(2):219-34. PMID: 20109051.
      View in: PubMed
    90. Hodel EM, Kabanywanyi AM, Malila A, Zanolari B, Mercier T, Beck HP, Buclin T, Olliaro P, Decosterd LA, Genton B. Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistance. PLoS One. 2009 Dec 14; 4(12):e8184. PMID: 20011529.
      View in: PubMed
    91. Geary TG, Woo K, McCarthy JS, Mackenzie CD, Horton J, Prichard RK, de Silva NR, Olliaro PL, Lazdins-Helds JK, Engels DA, Bundy DA. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol. 2010 Jan; 40(1):1-13. PMID: 19932111.
      View in: PubMed
    92. Gaudin K, Millet P, Fawaz F, Olliaro P, White NJ, Cassus-Coussère C, Agbahoungha U, Dubost JP. Investigation of porous graphitic carbon at high-temperature liquid chromatography with evaporative light scattering detection for the analysis of the drug combination artesunate--azithromycin for the treatment of severe malaria. J Chromatogr A. 2010 Jan 01; 1217(1):75-81. PMID: 19931089.
      View in: PubMed
    93. Harhay MO, Halpern SD, Harhay JS, Olliaro PL. Health care waste management: a neglected and growing public health problem worldwide. Trop Med Int Health. 2009 Nov; 14(11):1414-7. PMID: 19735368.
      View in: PubMed
    94. Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, Cohuet S, D'Alessandro U, Djimdé A, Karema C, Guthmann JP, Hamour S, Ndiaye JL, Mårtensson A, Rwagacondo C, Sagara I, Same-Ekobo A, Sirima SB, van den Broek I, Yeka A, Taylor WR, Dorsey G, Randrianarivelojosia M. Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Malar J. 2009 Aug 23; 8:203. PMID: 19698172.
      View in: PubMed
    95. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev. 2009 Jul 08; (3):CD007483. PMID: 19588433.
      View in: PubMed
    96. Olliaro P, Darley S, Laxminarayan R, Sundar S. Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India. Trop Med Int Health. 2009 Aug; 14(8):918-25. PMID: 19563434.
      View in: PubMed
    97. Danso-Appiah A, Garner P, Olliaro PL, Utzinger J. Treatment of urinary schistosomiasis: methodological issues and research needs identified through a Cochrane systematic review. Parasitology. 2009 Nov; 136(13):1837-49. PMID: 19493363.
      View in: PubMed
    98. Garner P, Gelband H, Graves P, Jones K, Maclehose H, Olliaro P. Systematic reviews in malaria: global policies need global reviews. Infect Dis Clin North Am. 2009 Jun; 23(2):387-404, Table of Contents. PMID: 19393915.
      View in: PubMed
    99. Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J. 2009 May 04; 8:89. PMID: 19413906.
      View in: PubMed
    100. Olliaro P. Management of fever and malaria - policy and practice. Trop Med Int Health. 2009 May; 14(5):488-90. PMID: 19320873.
      View in: PubMed
    101. Navaratnam V, Ramanathan S, Wahab MS, Siew Hua G, Mansor SM, Kiechel JR, Vaillant M, Taylor WR, Olliaro P. Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers. Eur J Clin Pharmacol. 2009 Aug; 65(8):809-21. PMID: 19404632.
      View in: PubMed
    102. Olliaro P, Wells TN. The global portfolio of new antimalarial medicines under development. Clin Pharmacol Ther. 2009 Jun; 85(6):584-95. PMID: 19404247.
      View in: PubMed
    103. Sirima SB, Tiono AB, Gansané A, Diarra A, Ouédraogo A, Konaté AT, Kiechel JR, Morgan CC, Olliaro PL, Taylor WR. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malar J. 2009 Mar 16; 8:48. PMID: 19291301.
      View in: PubMed
    104. Hodel EM, Zanolari B, Mercier T, Biollaz J, Keiser J, Olliaro P, Genton B, Decosterd LA. A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Apr 01; 877(10):867-86. PMID: 19249251.
      View in: PubMed
    105. Lai CS, Nair NK, Muniandy A, Mansor SM, Olliaro PL, Navaratnam V. Validation of high performance liquid chromatography-electrochemical detection methods with simultaneous extraction procedure for the determination of artesunate, dihydroartemisinin, amodiaquine and desethylamodiaquine in human plasma for application in clinical pharmacological studies of artesunate-amodiaquine drug combination. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Feb 15; 877(5-6):558-62. PMID: 19147417.
      View in: PubMed
    106. Olliaro P, Sundar S. Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India. Trop Med Int Health. 2009 Jan; 14(1):88-92. PMID: 19121150.
      View in: PubMed
    107. Gomes MF, Faiz MA, Gyapong JO, Warsame M, Agbenyega T, Babiker A, Baiden F, Yunus EB, Binka F, Clerk C, Folb P, Hassan R, Hossain MA, Kimbute O, Kitua A, Krishna S, Makasi C, Mensah N, Mrango Z, Olliaro P, Peto R, Peto TJ, Rahman MR, Ribeiro I, Samad R, White NJ. Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet. 2009 Feb 14; 373(9663):557-66. PMID: 19059639.
      View in: PubMed
    108. Brasseur P, Agnamey P, Gaye O, Cisse M, Badiane M, Vaillant M, Taylor WR, Olliaro P. Dosing accuracy of artesunate and amodiaquine as treatment for falciparum malaria in Casamance, Senegal. Trop Med Int Health. 2009 Jan; 14(1):79-87. PMID: 19021893.
      View in: PubMed
    109. Olliaro PL, Delenne H, Cisse M, Badiane M, Olliaro A, Vaillant M, Brasseur P. Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal. Malar J. 2008 Nov 07; 7:234. PMID: 18992140.
      View in: PubMed
    110. Sundar S, Rai M, Chakravarty J, Agarwal D, Agrawal N, Vaillant M, Olliaro P, Murray HW. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. Clin Infect Dis. 2008 Oct 15; 47(8):1000-6. PMID: 18781879.
      View in: PubMed
    111. Ashley EA, Pinoges L, Turyakira E, Dorsey G, Checchi F, Bukirwa H, van den Broek I, Zongo I, Urruta PP, van Herp M, Balkan S, Taylor WR, Olliaro P, Guthmann JP. Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children. Malar J. 2008 Aug 09; 7:154. PMID: 18691429.
      View in: PubMed
    112. Lee SJ, Stepniewska K, Anstey N, Ashley E, Barnes K, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton P, Nosten F, Olliaro P, Osario L, Pinoges L, Price R, Rowland M, Smithuis F, Taylor R, White NJ. The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria. Malar J. 2008 Aug 02; 7:149. PMID: 18673575.
      View in: PubMed
    113. Danso-Appiah A, Utzinger J, Liu J, Olliaro P. Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev. 2008 Jul 16; (3):CD000053. PMID: 18646057.
      View in: PubMed
    114. Olliaro P. Editorial commentary: mortality associated with severe Plasmodium falciparum malaria increases with age. Clin Infect Dis. 2008 Jul 15; 47(2):158-60. PMID: 18564928.
      View in: PubMed
    115. Basilico N, Bosisio E, Buelli F, Campiani G, Casagrande M, Castelli F, Coghi P, Corbett Y, Cortelezzi L, D'Alessandro S, Dell'Agli M, Esposito F, Fattorusso C, Fattorusso E, Finaurini S, Galli GV, Gemma S, Habluetzel A, Lucantoni L, Melato S, Monti D, Olliaro P, Omodeo-Salè F, Parapini S, Persico M, Rizzi M, Romeo S, Rossi F, Rusconi C, Sparatore A, Scafati OT, van den Bogaart E, Taramelli D, Vaiana N, Yerbanga S. Old and new targets for innovative antimalarial compounds: the different strategies of the Italian Malaria Network. Parassitologia. 2008 Jun; 50(1-2):133-6. PMID: 18693579.
      View in: PubMed
    116. Orrell C, Little F, Smith P, Folb P, Taylor W, Olliaro P, Barnes KI. Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers. Eur J Clin Pharmacol. 2008 Jul; 64(7):683-90. PMID: 18415093.
      View in: PubMed
    117. Olliaro P. Disease and drug interactions: treating malaria with artesunate plus amodiaquine in patients also receiving treatment for concomitant HIV infection. Clin Infect Dis. 2008 Apr 01; 46(7):992-3. PMID: 18444814.
      View in: PubMed
    118. Longo M, Zanoncelli S, Della Torre P, Rosa F, Giusti A, Colombo P, Brughera M, Mazué G, Olliaro P. Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX). Reprod Toxicol. 2008 Aug; 25(4):433-41. PMID: 18394862.
      View in: PubMed
    119. Janvier F, Morillon M, Olliaro P. [Visceral leishmaniasis: clinical sensitivity and resistance to various therapeutic agents]. Med Trop (Mars). 2008 Feb; 68(1):89-101. PMID: 18478781.
      View in: PubMed
    120. Olliaro P, Pinoges L, Checchi F, Vaillant M, Guthmann JP. Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment. Trop Med Int Health. 2008 Jan; 13(1):83-90. PMID: 18291006.
      View in: PubMed
    121. Vaillant M, Olliaro P. Geometric least squares means ratios for the analysis of Plasmodium falciparum in vitro susceptibility to antimalarial drugs. Malar J. 2007 Nov 26; 6:156. PMID: 18039388.
      View in: PubMed
    122. Brasseur P, Agnamey P, Gaye O, Vaillant M, Taylor WR, Olliaro PL. Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal. Malar J. 2007 Nov 15; 6:150. PMID: 18005408.
      View in: PubMed
    123. Sundar S, Olliaro PL. Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management. Ther Clin Risk Manag. 2007 Oct; 3(5):733-40. PMID: 18472998.
      View in: PubMed
    124. Olliaro P, Brasseur P. [Treatment of malaria: outlook]. Bull Acad Natl Med. 2007 Oct; 191(7):1285-92. PMID: 18447050.
      View in: PubMed
    125. Kindermans JM, Pilloy J, Olliaro P, Gomes M. Ensuring sustained ACT production and reliable artemisinin supply. Malar J. 2007 Sep 15; 6:125. PMID: 17868471.
      View in: PubMed
    126. Price RN, Dorsey G, Ashley EA, Barnes KI, Baird JK, d'Alessandro U, Guerin PJ, Laufer MK, Naidoo I, Nosten F, Olliaro P, Plowe CV, Ringwald P, Sibley CH, Stepniewska K, White NJ. World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Malar J. 2007 Sep 06; 6:119. PMID: 17822532.
      View in: PubMed
    127. Barnes KI, Lindegardh N, Ogundahunsi O, Olliaro P, Plowe CV, Randrianarivelojosia M, Gbotosho GO, Watkins WM, Sibley CH, White NJ. World Antimalarial Resistance Network (WARN) IV: clinical pharmacology. Malar J. 2007 Sep 06; 6:122. PMID: 17822537.
      View in: PubMed
    128. Lai CS, Nair NK, Mansor SM, Olliaro PL, Navaratnam V. An analytical method with a single extraction procedure and two separate high performance liquid chromatographic systems for the determination of artesunate, dihydroartemisinin and mefloquine in human plasma for application in clinical pharmacological studies of the drug combination. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Oct 01; 857(2):308-14. PMID: 17719858.
      View in: PubMed
    129. Kindermans JM, Vandenbergh D, Vreeke E, Olliaro P, D'Altilia JP. Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs). Malar J. 2007 Jul 10; 6:91. PMID: 17623092.
      View in: PubMed
    130. Obonyo CO, Taylor W, Ekvall H, Kaneko A, Ter Kuile F, Olliaro P, Bjorkman A, Oloo AJ. Effect of artesunate plus sulfadoxine-pyrimethamine on haematological recovery and anaemia, in Kenyan children with uncomplicated, Plasmodium falciparum malaria. Ann Trop Med Parasitol. 2007 Jun; 101(4):281-95. PMID: 17524243.
      View in: PubMed
    131. Osorio L, Gonzalez I, Olliaro P, Taylor WR. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia. Malar J. 2007 Feb 28; 6:25. PMID: 17328806.
      View in: PubMed
    132. Mugittu K, Priotto G, Guthmann JP, Kiguli J, Adjuik M, Snounou G, Beck HP, Mshinda H, Olliaro PL, Taylor WR. Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment. Trop Med Int Health. 2007 Feb; 12(2):219-23. PMID: 17300628.
      View in: PubMed
    133. Lalloo DG, Olukoya P, Olliaro P. Malaria in adolescence: burden of disease, consequences, and opportunities for intervention. Lancet Infect Dis. 2006 Dec; 6(12):780-93. PMID: 17123898.
      View in: PubMed
    134. Taylor W, Terlouw DJ, Olliaro PL, White NJ, Brasseur P, ter Kuile FO. Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria. Bull World Health Organ. 2006 Dec; 84(12):956-64. PMID: 17242831.
      View in: PubMed
    135. Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, Smith PG, Sriram N, Wongsrichanalai C, Linke R, O'Brien R, Perkins M, Cunningham J, Matsoso P, Nathanson CM, Olliaro P, Peeling RW, Ramsay A. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol. 2006 Dec; 4(12 Suppl):S20-32. PMID: 17366684.
      View in: PubMed
    136. Simpson JA, Agbenyega T, Barnes KI, Di Perri G, Folb P, Gomes M, Krishna S, Krudsood S, Looareesuwan S, Mansor S, McIlleron H, Miller R, Molyneux M, Mwenechanya J, Navaratnam V, Nosten F, Olliaro P, Pang L, Ribeiro I, Tembo M, van Vugt M, Ward S, Weerasuriya K, Win K, White NJ. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients. PLoS Med. 2006 Nov; 3(11):e444. PMID: 17132053.
      View in: PubMed
    137. Ashley EA, Lwin KM, McGready R, Simon WH, Phaiphun L, Proux S, Wangseang N, Taylor W, Stepniewska K, Nawamaneerat W, Thwai KL, Barends M, Leowattana W, Olliaro P, Singhasivanon P, White NJ, Nosten F. An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. Trop Med Int Health. 2006 Nov; 11(11):1653-60. PMID: 17054744.
      View in: PubMed
    138. Guthmann JP, Pinoges L, Checchi F, Cousens S, Balkan S, van Herp M, Legros D, Olliaro P. Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004. Antimicrob Agents Chemother. 2006 Nov; 50(11):3734-9. PMID: 16954313.
      View in: PubMed
    139. Mugittu K, Adjuik M, Snounou G, Ntoumi F, Taylor W, Mshinda H, Olliaro P, Beck HP. Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness. Trop Med Int Health. 2006 Sep; 11(9):1350-9. PMID: 16930256.
      View in: PubMed
    140. Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, Smith PG, Sriram N, Wongsrichanalai C, Linke R, O'Brien R, Perkins M, Cunningham J, Matsoso P, Nathanson CM, Olliaro P, Peeling RW, Ramsay A. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol. 2006 Sep; 4(9 Suppl):S21-31. PMID: 17034069.
      View in: PubMed
    141. Longo M, Zanoncelli S, Torre PD, Riflettuto M, Cocco F, Pesenti M, Giusti A, Colombo P, Brughera M, Mazué G, Navaratman V, Gomes M, Olliaro P. In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos. Reprod Toxicol. 2006 Nov; 22(4):797-810. PMID: 16959470.
      View in: PubMed
    142. Basano SA, Bianco A, Taylor WR, Olliaro P, Camargo LM. An in vivo test to assess mefloquine 25 mg/kg for the treatment of uncomplicated falciparum malaria in Rondônia, Brazil. Braz J Infect Dis. 2006 Aug; 10(4):279-82. PMID: 17293912.
      View in: PubMed
    143. Agnamey P, Brasseur P, de Pecoulas PE, Vaillant M, Olliaro P. Plasmodium falciparum in vitro susceptibility to antimalarial drugs in Casamance (southwestern Senegal) during the first 5 years of routine use of artesunate-amodiaquine. Antimicrob Agents Chemother. 2006 Apr; 50(4):1531-4. PMID: 16569876.
      View in: PubMed
    144. Alvar J, Croft S, Olliaro P. Chemotherapy in the treatment and control of leishmaniasis. Adv Parasitol. 2006; 61:223-74. PMID: 16735166.
      View in: PubMed
    145. Senok AC, Nelson EA, Li K, Ismaeel AR, Olliaro P, Oppenheimer SJ. Ultrastructural assessment of Plasmodium falciparum in age-fractionated thalassaemic erythrocytes. Parasitol Res. 2006 Mar; 98(4):381-4. PMID: 16362341.
      View in: PubMed
    146. Olliaro PL, Guerin PJ, Gerstl S, Haaskjold AA, Rottingen JA, Sundar S. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis. 2005 Dec; 5(12):763-74. PMID: 16310148.
      View in: PubMed
    147. Ramanathan S, Karupiah S, Nair NK, Olliaro PL, Navaratnam V, Wernsdorfer WH, Mansor SM. A new and simple solid-phase extraction method for LC determination of pyronaridine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 25; 824(1-2):45-50. PMID: 16046285.
      View in: PubMed
    148. Mårtensson A, Strömberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, Olliaro P, Ali AS, Björkman A. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis. 2005 Oct 15; 41(8):1079-86. PMID: 16163624.
      View in: PubMed
    149. Agnamey P, Brasseur P, Cisse M, Gaye O, Dumoulin J, Rigal J, Taylor WR, Olliaro P. Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal. Trop Med Int Health. 2005 Sep; 10(9):926-33. PMID: 16135201.
      View in: PubMed
    150. Olliaro P. Drug resistance hampers our capacity to roll back malaria. Clin Infect Dis. 2005 Aug 15; 41 Suppl 4:S247-57. PMID: 16032560.
      View in: PubMed
    151. Longo M, Zanoncelli S, Manera D, Brughera M, Colombo P, Lansen J, Mazué G, Gomes M, Taylor WR, Olliaro P. Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro. Reprod Toxicol. 2006 Jan; 21(1):83-93. PMID: 16026965.
      View in: PubMed
    152. Biot C, Taramelli D, Forfar-Bares I, Maciejewski LA, Boyce M, Nowogrocki G, Brocard JS, Basilico N, Olliaro P, Egan TJ. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity. Mol Pharm. 2005 May-Jun; 2(3):185-93. PMID: 15934779.
      View in: PubMed
    153. Olliaro P. Congenital toxoplasmosis. Clin Evid. 2004 Dec; (12):1058-61. PMID: 15865702.
      View in: PubMed
    154. Safeukui I, Mangou F, Malvy D, Vincendeau P, Mossalayi D, Haumont G, Vatan R, Olliaro P, Millet P. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway. Biochem Pharmacol. 2004 Nov 15; 68(10):1903-10. PMID: 15476661.
      View in: PubMed
    155. Stepniewska K, Taylor WR, Mayxay M, Price R, Smithuis F, Guthmann JP, Barnes K, Myint HY, Adjuik M, Olliaro P, Pukrittayakamee S, Looareesuwan S, Hien TT, Farrar J, Nosten F, Day NP, White NJ. In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother. 2004 Nov; 48(11):4271-80. PMID: 15504852.
      View in: PubMed
    156. Parapini S, Basilico N, Mondani M, Olliaro P, Taramelli D, Monti D. Evidence that haem iron in the malaria parasite is not needed for the antimalarial effects of artemisinin. FEBS Lett. 2004 Sep 24; 575(1-3):91-4. PMID: 15388339.
      View in: PubMed
    157. Olliaro P, Smith PG. The European and developing countries clinical trails partnership. J HIV Ther. 2004 Sep; 9(3):53-6. PMID: 15534561.
      View in: PubMed
    158. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004 Jan 03; 363(9402):9-17. PMID: 14723987.
      View in: PubMed
    159. Olliaro PL, Taylor WR. Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A review. J Postgrad Med. 2004 Jan-Mar; 50(1):40-4. PMID: 15047998.
      View in: PubMed
    160. Gil VS, Ferreira MC, d'Alva FS, d'Abreu JA, Will IM, Gomes ML, Castelli F, Taylor WR, Olliaro P, D'Alessandro U. Efficacy of artesunate plus chloroquine for uncomplicated malaria in children in Sao Tome and Principe: a double-blind, randomized, controlled trial. Trans R Soc Trop Med Hyg. 2003 Nov-Dec; 97(6):703-6. PMID: 16117967.
      View in: PubMed
    161. Olliaro PL, Taylor WR. Antimalarial compounds: from bench to bedside. J Exp Biol. 2003 Nov; 206(Pt 21):3753-9. PMID: 14506210.
      View in: PubMed
    162. Taylor WR, Rigal J, Olliaro PL. Drug resistant falciparum malaria and the use of artesunate-based combinations: focus on clinical trials sponsored by TDR. J Vector Borne Dis. 2003 Sep-Dec; 40(3-4):65-72. PMID: 15119074.
      View in: PubMed
    163. Obonyo CO, Ochieng F, Taylor WR, Ochola SA, Mugitu K, Olliaro P, ter Kuile F, Oloo AJ. Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial. Trans R Soc Trop Med Hyg. 2003 Sep-Oct; 97(5):585-91. PMID: 15307433.
      View in: PubMed
    164. Asilian A, Jalayer T, Nilforooshzadeh M, Ghassemi RL, Peto R, Wayling S, Olliaro P, Modabber F. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. Bull World Health Organ. 2003; 81(5):353-9. PMID: 12856053.
      View in: PubMed
    165. Olliaro P. Congenital toxoplasmosis. Clin Evid. 2003 Jun; (9):763-6. PMID: 12967389.
      View in: PubMed
    166. Priotto G, Kabakyenga J, Pinoges L, Ruiz A, Eriksson T, Coussement F, Ngambe T, Taylor WR, Perea W, Guthmann JP, Olliaro P, Legros D. Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial. Trans R Soc Trop Med Hyg. 2003 May-Jun; 97(3):325-30. PMID: 15228253.
      View in: PubMed
    167. Omodeo-Salè F, Motti A, Basilico N, Parapini S, Olliaro P, Taramelli D. Accelerated senescence of human erythrocytes cultured with Plasmodium falciparum. Blood. 2003 Jul 15; 102(2):705-11. PMID: 12649148.
      View in: PubMed
    168. Haynes RK, Monti D, Taramelli D, Basilico N, Parapini S, Olliaro P. Artemisinin antimalarials do not inhibit hemozoin formation. Antimicrob Agents Chemother. 2003 Mar; 47(3):1175. PMID: 12604568.
      View in: PubMed
    169. von Seidlein L, Walraven G, Milligan PJ, Alexander N, Manneh F, Deen JL, Coleman R, Jawara M, Lindsay SW, Drakeley C, De Martin S, Olliaro P, Bennett S, Schim van der Loeff M, Okunoye K, Targett GA, McAdam KP, Doherty JF, Greenwood BM, Pinder M. The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans R Soc Trop Med Hyg. 2003 Mar-Apr; 97(2):217-25. PMID: 14584381.
      View in: PubMed
    170. Olliaro PL, Ridley RG, Engel J, Sindermann H, Bryceson AD. Miltefosine in visceral leishmaniasis. Lancet Infect Dis. 2003 Feb; 3(2):70. PMID: 12560189.
      View in: PubMed
    171. Pradines B, Vial H, Olliaro P. [Malaria prophylaxis and treatment: problems, recent developments and perspectives]. Med Trop (Mars). 2003; 63(1):79-98. PMID: 12891756.
      View in: PubMed
    172. Olliaro P, Mussano P. Amodiaquine for treating malaria. Cochrane Database Syst Rev. 2003; (2):CD000016. PMID: 12804382.
      View in: PubMed
    173. Olliaro P. Congenital toxoplasmosis. Clin Evid. 2002 Dec; (8):680-3. PMID: 12603905.
      View in: PubMed
    174. Guerin PJ, Olliaro P, Nosten F, Druilhe P, Laxminarayan R, Binka F, Kilama WL, Ford N, White NJ. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis. 2002 Sep; 2(9):564-73. PMID: 12206972.
      View in: PubMed
    175. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Bryceson AD. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2002 Aug; 2(8):494-501. PMID: 12150849.
      View in: PubMed
    176. Monti D, Basilico N, Parapini S, Pasini E, Olliaro P, Taramelli D. Does chloroquine really act through oxidative stress? FEBS Lett. 2002 Jul 03; 522(1-3):3-5. PMID: 12095608.
      View in: PubMed
    177. Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N. Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet. 2002 Jun 22; 359(9324):2188-94. PMID: 12090998.
      View in: PubMed
    178. Olliaro P. Congenital toxoplasmosis. Clin Evid. 2002 Jun; (7):623-6. PMID: 12230689.
      View in: PubMed
    179. Olliaro P, Lazdins J, Guhl F. Developments in the treatment of leishmaniasis and trypanosomiasis. Expert Opin Emerg Drugs. 2002 May; 7(1):61-7. PMID: 15989536.
      View in: PubMed
    180. Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WR. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet. 2002 Apr 20; 359(9315):1365-72. PMID: 11978332.
      View in: PubMed
    181. Olliaro PL, Nair NK, Sathasivam K, Mansor SM, Navaratnam V. Pharmacokinetics of artesunate after single oral administration to rats. BMC Pharmacol. 2001; 1:12. PMID: 11835690.
      View in: PubMed
    182. Olliaro P, Taylor WR, Rigal J. Controlling malaria: challenges and solutions. Trop Med Int Health. 2001 Nov; 6(11):922-7. PMID: 11703847.
      View in: PubMed
    183. Trouiller P, Torreele E, Olliaro P, White N, Foster S, Wirth D, Pécoul B. Drugs for neglected diseases: a failure of the market and a public health failure? Trop Med Int Health. 2001 Nov; 6(11):945-51. PMID: 11703850.
      View in: PubMed
    184. Orrell C, Taylor WR, Olliaro P. Acute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and artesunate. Trans R Soc Trop Med Hyg. 2001 Sep-Oct; 95(5):517-8. PMID: 11706664.
      View in: PubMed
    185. Omodeo-Salè F, Monti D, Olliaro P, Taramelli D. Prooxidant activity of beta-hematin (synthetic malaria pigment) in arachidonic acid micelles and phospholipid large unilamellar vesicles. Biochem Pharmacol. 2001 Apr 15; 61(8):999-1009. PMID: 11286991.
      View in: PubMed
    186. Olliaro PL, Haynes RK, Meunier B, Yuthavong Y. Possible modes of action of the artemisinin-type compounds. Trends Parasitol. 2001 Mar; 17(3):122-6. PMID: 11286794.
      View in: PubMed
    187. Olliaro P. Mode of action and mechanisms of resistance for antimalarial drugs. Pharmacol Ther. 2001 Feb; 89(2):207-19. PMID: 11316521.
      View in: PubMed
    188. Olliaro PL, Vijayan R, Inbasegaran K, Lang CC, Looareesuwan S. Drug studies in developing countries. Bull World Health Organ. 2001; 79(9):894-5. PMID: 11584742.
      View in: PubMed
    189. Taramelli D, Recalcati S, Basilico N, Olliaro P, Cairo G. Macrophage preconditioning with synthetic malaria pigment reduces cytokine production via heme iron-dependent oxidative stress. Lab Invest. 2000 Dec; 80(12):1781-8. PMID: 11140691.
      View in: PubMed
    190. Parapini S, Basilico N, Pasini E, Egan TJ, Olliaro P, Taramelli D, Monti D. Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Exp Parasitol. 2000 Dec; 96(4):249-56. PMID: 11162378.
      View in: PubMed
    191. Wilairatna P, Krudsood S, Silachamroon U, Singhasivanon P, Vannaphan S, Faithong S, Klabprasit M, Bangchang SN, Olliaro P, Looareesuwan S. Clinical trial of sequential treatments of moderately severe and severe malaria with dihydroartemisinin suppository followed by mefloquine in Thailand. Am J Trop Med Hyg. 2000 Nov-Dec; 63(5-6):290-4. PMID: 11421380.
      View in: PubMed
    192. Olliaro P. Microbial infection. IDrugs. 2000 Oct; 3(10):1134-5. PMID: 16049822.
      View in: PubMed
    193. Navaratnam V, Mansor SM, Sit NW, Grace J, Li Q, Olliaro P. Pharmacokinetics of artemisinin-type compounds. Clin Pharmacokinet. 2000 Oct; 39(4):255-70. PMID: 11069212.
      View in: PubMed
    194. Thakur CP, Kanyok TP, Pandey AK, Sinha GP, Messick C, Olliaro P. Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. Trans R Soc Trop Med Hyg. 2000 Jul-Aug; 94(4):432-3. PMID: 11127251.
      View in: PubMed
    195. Thakur CP, Kanyok TP, Pandey AK, Sinha GP, Zaniewski AE, Houlihan HH, Olliaro P. A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2000 Jul-Aug; 94(4):429-31. PMID: 11127250.
      View in: PubMed
    196. von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, Coleman R, Ude JI, Sadiq A, Duraisingh M, Warhurst D, Alloueche A, Targett G, McAdam K, Greenwood B, Walraven G, Olliaro P, Doherty T. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet. 2000 Jan 29; 355(9201):352-7. PMID: 10665554.
      View in: PubMed
    197. Olliaro P, Mussano P. Amodiaquine for treating malaria. Cochrane Database Syst Rev. 2000; (2):CD000016. PMID: 10796468.
      View in: PubMed
    198. McIntosh HM, Olliaro P. Artemisinin derivatives for treating uncomplicated malaria. Cochrane Database Syst Rev. 2000; (2):CD000256. PMID: 10796519.
      View in: PubMed
    199. McIntosh HM, Olliaro P. Artemisinin derivatives for treating severe malaria. Cochrane Database Syst Rev. 2000; (2):CD000527. PMID: 10796551.
      View in: PubMed
    200. Olliaro P, Lombardi L, Frigerio S, Basilico N, Taramelli D, Monti D. Phagocytosis of hemozoin (native and synthetic malaria pigment), and Plasmodium falciparum intraerythrocyte-stage parasites by human and mouse phagocytes. Ultrastruct Pathol. 2000 Jan-Feb; 24(1):9-13. PMID: 10721147.
      View in: PubMed
    201. Boelaert JR, Taramelli D, Olliaro P. Chloroquine enhances viral replication and murine disease. Am J Trop Med Hyg. 2000 Jan; 62(1):1-3. PMID: 10761717.
      View in: PubMed
    202. Brasseur P, Guiguemde R, Diallo S, Guiyedi V, Kombila M, Ringwald P, Olliaro P. Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa. Trans R Soc Trop Med Hyg. 1999 Nov-Dec; 93(6):645-50. PMID: 10717757.
      View in: PubMed
    203. Matteelli A, Olliaro P, Signorini L, Cadeo G, Scalzini A, Bonazzi L, Caligaris S, Tomasoni L, Tebaldi A, Carosi G. Tolerability of twice-weekly rifabutin-isoniazid combinations versus daily isoniazid for latent tuberculosis in HIV-infected subjects: a pilot study. Int J Tuberc Lung Dis. 1999 Nov; 3(11):1043-6. PMID: 10587327.
      View in: PubMed
    204. Di Perri G, Olliaro P, Ward S, Allegranzi B, Bonora S, Concia E. Rapid absorption and clinical effectiveness of intragastric mefloquine in the treatment of cerebral malaria in African children. J Antimicrob Chemother. 1999 Oct; 44(4):573-6. PMID: 10588325.
      View in: PubMed
    205. Taramelli D, Monti D, Basilico N, Parapini S, Omodeo-Salé F, Olliaro P. A fine balance between oxidised and reduced haem controls the survival of intraerythrocytic plasmodia. Parassitologia. 1999 Sep; 41(1-3):205-8. PMID: 10697858.
      View in: PubMed
    206. Doherty JF, Sadiq AD, Bayo L, Alloueche A, Olliaro P, Milligan P, von Seidlein L, Pinder M. A randomized safety and tolerability trial of artesunate plus sulfadoxine--pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children. Trans R Soc Trop Med Hyg. 1999 Sep-Oct; 93(5):543-6. PMID: 10696418.
      View in: PubMed
    207. Monti D, Vodopivec B, Basilico N, Olliaro P, Taramelli D. A novel endogenous antimalarial: Fe(II)-protoporphyrin IX alpha (heme) inhibits hematin polymerization to beta-hematin (malaria pigment) and kills malaria parasites. Biochemistry. 1999 Jul 13; 38(28):8858-63. PMID: 10413458.
      View in: PubMed
    208. Trouiller P, Olliaro PL. Drug development output: what proportion for tropical diseases? Lancet. 1999 Jul 10; 354(9173):164. PMID: 10408518.
      View in: PubMed
    209. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK, Danis M, Greenwood BM, Anderson RM, Olliaro P. Averting a malaria disaster. Lancet. 1999 Jun 05; 353(9168):1965-7. PMID: 10371589.
      View in: PubMed
    210. Olliaro PL, Yuthavong Y. An overview of chemotherapeutic targets for antimalarial drug discovery. Pharmacol Ther. 1999 Feb; 81(2):91-110. PMID: 10190581.
      View in: PubMed
    211. Olliaro P, Jha TK. Clarification of comments on trial of aminosidine in visceral leishmaniasis. BMJ. 1998 Oct 31; 317(7167):1250. PMID: 9794877.
      View in: PubMed
    212. Omodeo-Salè F, Basilico N, Folini M, Olliaro P, Taramelli D. Macrophage populations of different origins have distinct susceptibilities to lipid peroxidation induced by beta-haematin (malaria pigment). FEBS Lett. 1998 Aug 21; 433(3):215-8. PMID: 9744797.
      View in: PubMed
    213. Basilico N, Pagani E, Monti D, Olliaro P, Taramelli D. A microtitre-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs. J Antimicrob Chemother. 1998 Jul; 42(1):55-60. PMID: 9700528.
      View in: PubMed
    214. Di Perri G, Olliaro P, Nardi S, Deganello R, Allegranzi B, Bonora S, Vento S, Concia E. Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands. Acta Trop. 1998 Jun 15; 70(1):25-33. PMID: 9707362.
      View in: PubMed
    215. Looareesuwan S, Olliaro P, White NJ, Chongsuphajaisiddhi T, Sabcharoen A, Thimasarn K, Nosten F, Singhasivanon P, Supavej S, Khusmith S, Wylings S, Kanyok T, Walsh D, Leggat PA, Doberstyn EB. Consensus recommendation on the treatment of malaria in Southeast Asia. Southeast Asian J Trop Med Public Health. 1998 Jun; 29(2):355-60. PMID: 9886127.
      View in: PubMed
    216. Jha TK, Olliaro P, Thakur CP, Kanyok TP, Singhania BL, Singh IJ, Singh NK, Akhoury S, Jha S. Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. BMJ. 1998 Apr 18; 316(7139):1200-5. PMID: 9583927.
      View in: PubMed
    217. Eddleston M, Weerasuriya K, Olliaro P. Ethics review and clinical trials. Lancet. 1998 Apr 04; 351(9108):1066. PMID: 9546546.
      View in: PubMed
    218. Vexenat JA, Olliaro PL, Fonseca de Castro JA, Cavalcante R, Furtado Campos JH, Tavares JP, Miles MA. Clinical recovery and limited cure in canine visceral leishmaniasis treated with aminosidine (paromomycin). Am J Trop Med Hyg. 1998 Apr; 58(4):448-53. PMID: 9574790.
      View in: PubMed
    219. Winstanley P, Olliaro P. Clinical trials of chemotherapy for falciparum malaria. Expert Opin Investig Drugs. 1998 Feb; 7(2):261-71. PMID: 15991958.
      View in: PubMed
    220. Taramelli D, Basilico N, De Palma AM, Saresella M, Ferrante P, Mussoni L, Olliaro P. The effect of synthetic malaria pigment (beta-haematin) on adhesion molecule expression and interleukin-6 production by human endothelial cells. Trans R Soc Trop Med Hyg. 1998 Jan-Feb; 92(1):57-62. PMID: 9692153.
      View in: PubMed
    221. Gomes M, Olliaro P, Folb P. What role can public health institutions play in drug development for the poor? A case study of artesunate. Med Trop (Mars). 1998; 58(3 Suppl):97-100. PMID: 10212912.
      View in: PubMed
    222. White NJ, Olliaro P. Artemisinin and derivatives in the treatment of uncomplicated malaria. Med Trop (Mars). 1998; 58(3 Suppl):54-6. PMID: 10212899.
      View in: PubMed
    223. Ribeiro IR, Olliaro P. Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Med Trop (Mars). 1998; 58(3 Suppl):50-3. PMID: 10212898.
      View in: PubMed
    224. McIntosh HM, Olliaro P. Treatment of uncomplicated malaria with artemisinin derivatives. A systematic review of randomised controlled trials. Med Trop (Mars). 1998; 58(3 Suppl):57-8. PMID: 10212900.
      View in: PubMed
    225. McIntosh HM, Olliaro P. Treatment of severe malaria with artemisinin derivatives. A systematic review of randomised controlled trials. Med Trop (Mars). 1998; 58(3 Suppl):61-2. PMID: 10212902.
      View in: PubMed
    226. Trouiller P, Olliaro PL. Drug development output from 1975 to 1996: what proportion for tropical diseases? Int J Infect Dis. 1998-1999 Winter; 3(2):61-3. PMID: 10225981.
      View in: PubMed
    227. Farina C, Olliaro P, Goglio A. Failure to detect significant in-vitro activity of artemether and beta-arteether against bacteria and fungi by an agar dilution test. J Antimicrob Chemother. 1997 Nov; 40(5):743-5. PMID: 9421333.
      View in: PubMed
    228. Looareesuwan S, Wilairatana P, Molunto W, Chalermrut K, Olliaro P, Andrial M. A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand. Am J Trop Med Hyg. 1997 Sep; 57(3):348-53. PMID: 9311648.
      View in: PubMed
    229. Olliaro P, Castelli F. Plasmodium falciparum: an electronmicroscopy study of caveolae and trafficking between the parasite and the extracellular medium. Int J Parasitol. 1997 Sep; 27(9):1007-12. PMID: 9363482.
      View in: PubMed
    230. Di Perri G, Olliaro P, Nardi S, Allegranzi B, Deganello R, Vento S, Lanzafame M, Cazzadori A, Bonora S, Concia E. The ParaSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg. 1997 Jul-Aug; 91(4):403-5. PMID: 9373633.
      View in: PubMed
    231. Neva FA, Ponce C, Ponce E, Kreutzer R, Modabber F, Olliaro P. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin. Trans R Soc Trop Med Hyg. 1997 Jul-Aug; 91(4):473-5. PMID: 9373659.
      View in: PubMed
    232. Basilico N, Monti D, Olliaro P, Taramelli D. Non-iron porphyrins inhibit beta-haematin (malaria pigment) polymerisation. FEBS Lett. 1997 Jun 09; 409(2):297-9. PMID: 9202165.
      View in: PubMed
    233. Ambroise-Thomas P, Olliaro P. Malaria vaccine. Lancet. 1996 Nov 16; 348(9038):1377-8. PMID: 8918284.
      View in: PubMed
    234. Olliaro P, Nevill C, LeBras J, Ringwald P, Mussano P, Garner P, Brasseur P. Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet. 1996 Nov 02; 348(9036):1196-201. PMID: 8898036.
      View in: PubMed
    235. McGregor MM, Olliaro P, Wolmarans L, Mabuza B, Bredell M, Felten MK, Fourie PB. Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosis. Am J Respir Crit Care Med. 1996 Nov; 154(5):1462-7. PMID: 8912765.
      View in: PubMed
    236. White NJ, Olliaro PL. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol Today. 1996 Oct; 12(10):399-401. PMID: 15275291.
      View in: PubMed
    237. Thakur CP, Pandey AK, Sinha GP, Roy S, Behbehani K, Olliaro P. Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. Trans R Soc Trop Med Hyg. 1996 May-Jun; 90(3):319-22. PMID: 8758093.
      View in: PubMed
    238. Looareesuwan S, Olliaro P, Kyle D, Wernsdorfer W. Pyronaridine. Lancet. 1996 Apr 27; 347(9009):1189-90. PMID: 8609791.
      View in: PubMed
    239. Lee CN, Lin TP, Chang MF, Jimenez MV, Dolfi L, Olliaro P. Rifabutin as salvage therapy for cases of chronic multidrug-resistant pulmonary tuberculosis in Taiwan. J Chemother. 1996 Apr; 8(2):137-43. PMID: 8708745.
      View in: PubMed
    240. Dautzenberg B, Olliaro P, Ruf B, Esposito R, Opravil M, Hoy JF, Rozenbaum W, Carosi GP, Micoud M, L'Age M, Pirotta N, Sassella D. Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDS. Clin Infect Dis. 1996 Apr; 22(4):705-8. PMID: 8729209.
      View in: PubMed
    241. Gonzales Montanler J, Shoenfelder J, Dolfi L, Olliaro P. Rifabutin-containing regimens for pulmonary tuberculosis: early assessment of treatment effectiveness. Tuber Lung Dis. 1996 Feb; 77(1):100. PMID: 8733426.
      View in: PubMed
    242. Olliaro P, Cattani J, Wirth D. Malaria, the submerged disease. JAMA. 1996 Jan 17; 275(3):230-3. PMID: 8604177.
      View in: PubMed
    243. Asilian A, Jalayer T, Whitworth JA, Ghasemi RL, Nilforooshzadeh M, Olliaro P. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg. 1995 Dec; 53(6):648-51. PMID: 8561269.
      View in: PubMed
    244. Taramelli D, Basilico N, Pagani E, Grande R, Monti D, Ghione M, Olliaro P. The heme moiety of malaria pigment (beta-hematin) mediates the inhibition of nitric oxide and tumor necrosis factor-alpha production by lipopolysaccharide-stimulated macrophages. Exp Parasitol. 1995 Dec; 81(4):501-11. PMID: 8542991.
      View in: PubMed
    245. Ben Salah A, Zakraoui H, Zaatour A, Ftaiti A, Zaafouri B, Garraoui A, Olliaro PL, Dellagi K, Ben Ismail R. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment. Am J Trop Med Hyg. 1995 Aug; 53(2):162-6. PMID: 7677218.
      View in: PubMed
    246. Olliaro PL, Goldberg DE. The plasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitol Today. 1995 Aug; 11(8):294-7. PMID: 15275326.
      View in: PubMed
    247. Neal RA, Allen S, McCoy N, Olliaro P, Croft SL. The sensitivity of Leishmania species to aminosidine. J Antimicrob Chemother. 1995 May; 35(5):577-84. PMID: 7592170.
      View in: PubMed
    248. Thakur CP, Bhowmick S, Dolfi L, Olliaro P. Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial. Trans R Soc Trop Med Hyg. 1995 Mar-Apr; 89(2):219-23. PMID: 7778155.
      View in: PubMed
    249. Olliaro PL, Trigg PI. Status of antimalarial drugs under development. Bull World Health Organ. 1995; 73(5):565-71. PMID: 8846482.
      View in: PubMed
    250. Scaglia M, Atzori C, Marchetti G, Orso M, Maserati R, Orani A, Novati S, Olliaro P. Effectiveness of aminosidine (paromomycin) sulfate in chronic Cryptosporidium diarrhea in AIDS patients: an open, uncontrolled, prospective clinical trial. J Infect Dis. 1994 Nov; 170(5):1349-50. PMID: 7963746.
      View in: PubMed
    251. Soto J, Grogl M, Berman J, Olliaro P. Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1994 Nov-Dec; 88(6):695-8. PMID: 7886777.
      View in: PubMed
    252. Olliaro P, Gorini G, Jabes D, Regazzetti A, Rossi R, Marchetti A, Tinelli C, Della Bruna C. In-vitro and in-vivo activity of rifabutin against Toxoplasma gondii. J Antimicrob Chemother. 1994 Nov; 34(5):649-57. PMID: 7706160.
      View in: PubMed
    253. Jabès D, Della Bruna C, Rossi R, Olliaro P. Effectiveness of rifabutin alone or in combination with isoniazid in preventive therapy of mouse tuberculosis. Antimicrob Agents Chemother. 1994 Oct; 38(10):2346-50. PMID: 7840568.
      View in: PubMed
    254. Gonzalez-Montaner LJ, Natal S, Yongchaiyud P, Olliaro P. Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin. Rifabutin Study Group. Tuber Lung Dis. 1994 Oct; 75(5):341-7. PMID: 7841427.
      View in: PubMed
    255. Della Bruna C, Olliaro P. Setting breakpoints for assessing the sensitivity of mycobacteria to rifabutin in vitro. J Antimicrob Chemother. 1994 Jul; 34(1):184-6. PMID: 7961209.
      View in: PubMed
    256. Olliaro P, Dautzenberg B. Control of the body burden of M. avium complex is associated with improved quality of life and prolonged survival of patients with AIDS: a prospective trial with rifabutin combined with isoniazid, clofazimine, ethambutol. J Chemother. 1994 Jun; 6(3):189-96. PMID: 7983502.
      View in: PubMed
    257. Neal RA, Murphy AG, Olliaro P, Croft SL. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1994 Mar-Apr; 88(2):223-5. PMID: 8036682.
      View in: PubMed
    258. Giacchino R, Tasso L, Losurdo G, Castagnola E, Olliaro P. Safety of rifabutin in a three-month-old infant. Pediatr Infect Dis J. 1994 Feb; 13(2):164. PMID: 8190549.
      View in: PubMed
    259. Olliaro P, Regazzetti A, Marchetti AL, Lanzarini P, Spinillo A, Gorini G. Prevalence of chlamydial antibody in pregnancy. A matched-pair study. Eur J Epidemiol. 1994 Feb; 10(1):47-50. PMID: 7957790.
      View in: PubMed
    260. Olliaro P. How plasmodium secures nutrients: new targets for drugs? Parasitol Today. 1994 Jan; 10(1):4-5. PMID: 15275554.
      View in: PubMed
    261. Olliaro P, Marchetti A, Regazzetti A, Fabbi M, Gorini G. Toxoplasma gondii virulence: changing pattern under different maintenance conditions. Parassitologia. 1993 Dec; 35(1-3):17-9. PMID: 8065815.
      View in: PubMed
    262. Ji B, Truffot-Pernot C, Lacroix C, Raviglione MC, O'Brien RJ, Olliaro P, Roscigno G, Grosset J. Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis. 1993 Dec; 148(6 Pt 1):1541-6. PMID: 8256897.
      View in: PubMed
    263. Olliaro PL, Trigg PI. Antimalarial resistance and health policies. Parasitol Today. 1993 Sep; 9(9):334. PMID: 15463798.
      View in: PubMed
    264. Olliaro PL, Bryceson AD. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today. 1993 Sep; 9(9):323-8. PMID: 15463794.
      View in: PubMed
    265. Thakur CP, Olliaro P, Gothoskar S, Bhowmick S, Choudhury BK, Prasad S, Kumar M, Verma BB. Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India. Trans R Soc Trop Med Hyg. 1992 Nov-Dec; 86(6):615-6. PMID: 1337634.
      View in: PubMed
    266. Scott JA, Davidson RN, Moody AH, Grant HR, Felmingham D, Scott GM, Olliaro P, Bryceson AD. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans R Soc Trop Med Hyg. 1992 Nov-Dec; 86(6):617-9. PMID: 1287915.
      View in: PubMed
    267. Mancini P, Pasqua F, Mazzei L, Olliaro P. Rifabutin treatment for tuberculosis patients with liver function abnormalities. J Antimicrob Chemother. 1992 Aug; 30(2):242. PMID: 1328137.
      View in: PubMed
    268. Olliaro P, Regazzetti A, Gorini G, Milano F, Marchetti A, Rondanelli EG. Chlamydia trachomatis infection in "sine causa" recurrent abortion. Boll Ist Sieroter Milan. 1991-1992; 70(1-2):467-70. PMID: 1727021.
      View in: PubMed
    269. Milano F, Gorini G, Olliaro P, Astori M, Furiosi G, Trimarchi F. Evaluation of diagnostic procedures in chlamydial eye infection. Ophthalmologica. 1991; 203(3):114-7. PMID: 1775298.
      View in: PubMed
    270. Gorini G, Milano F, Olliaro P, Regazzetti A, Rondanelli EG. Chlamydia trachomatis infection in primary unexplained infertility. Eur J Epidemiol. 1990 Sep; 6(3):335-8. PMID: 2253739.
      View in: PubMed
    271. Olliaro P, Castelli F, Caligaris S, Matteelli A, Carosi G. Ultrastructural features of host-parasite interactions in "in vitro" cultures of Plasmodium falciparum. Microbiologica. 1990 Apr; 13(2):137-44. PMID: 2191194.
      View in: PubMed
    272. Chippaux JP, Massougbodji A, Olliaro P, Gay F, Caligaris S, Danis M. Sensitivity in vitro of Plasmodium falciparum to chloroquine and mefloquine in two regions of Benin. Trans R Soc Trop Med Hyg. 1989 Sep-Oct; 83(5):584-5. PMID: 2694495.
      View in: PubMed
    273. Olliaro P, Castelli F, Caligaris S, Druilhe P, Carosi G. Ultrastructure of Plasmodium falciparum "in vitro". II. Morphological patterns of different quinolines effects. Microbiologica. 1989 Jan; 12(1):15-28. PMID: 2654570.
      View in: PubMed
    274. Olliaro P, Castelli F, Milano F, Filice G, Carosi G. Ultrastructure of Plasmodium falciparum "in vitro". I. Base-line for drug effects evaluation. Microbiologica. 1989 Jan; 12(1):7-14. PMID: 2654573.
      View in: PubMed
    275. Benzi Cipelli R, Gorini G, Ippoliti G, Olliaro P, Campana C. [Presence of auto-antibodies in patients who are candidates for heart transplant]. Quad Sclavo Diagn. 1987 Dec; 23(4):403-8. PMID: 3334102.
      View in: PubMed
    276. Rondanelli R, Guaglio R, Sartirana E, Zizzi E, Olliaro P, Benzi Cipelli R. Evaluation of the cytotoxic activity of some alkaloids from Epinetrum delagoense Diels. I. Farmaco Prat. 1986 Jun; 41(6):185-9. PMID: 3091394.
      View in: PubMed
    277. Rondanelli R, Guaglio R, Guarnone E, Brè E, Olliaro P, Benzi Cipelli R. Cytotoxic activity of some alkaloids from Epinetrum delagoense Diels: electron microscopy studies. II. Farmaco Prat. 1986 Jun; 41(6):190-6. PMID: 3091395.
      View in: PubMed
    278. Filice G, Carnevale G, Lanzarini P, Castelli F, Olliaro P, Orsolini P, Carosi G, Rondanelli EG. Life cycle of P. carinii in the lung of immuno-compromised hosts: an ultrastructural study. Microbiologica. 1985 Oct; 8(4):319-28. PMID: 3877857.
      View in: PubMed
    279. Guaschino R, Alesso D, Olliaro P, Mazzucco L. Plasma-exchange plus high-dose intravenous gamma globulin for chronic thrombocytopenic purpura. Int J Artif Organs. 1985 May; 8(3):169. PMID: 4040892.
      View in: PubMed
    280. Filice G, Carnevale G, Meroni V, Olliaro P, Gagliardi V, Vaccari E, Carosi G. Detection of IgM-anti-toxoplasma antibodies in acute acquired and congenital toxoplasmosis. Boll Ist Sieroter Milan. 1984; 63(5):453-7. PMID: 6397211.
      View in: PubMed
    281. Bosatra M, Jucci A, Olliaro P, Quacci D, Sacchi S. In vitro fibroblast and dermis fibroblast activation by laser irradiation at low energy. An electron microscopic study. Dermatologica. 1984; 168(4):157-62. PMID: 6724069.
      View in: PubMed
    282. Filice G, Meroni V, Carnevale G, Olliaro P, Carosi G. Comparison of ELISA and indirect immunofluorescence in the detection of IgG and IgM antitoxoplasma antibodies. Boll Ist Sieroter Milan. 1983 Nov 30; 62(5):445-50. PMID: 6367772.
      View in: PubMed
    283. Carosi G, Benzi-Cipelli R, Filice G, Gorini G, Carnevale G, Olliaro P. [Effect of josamycin on Toxoplasma gondii "in vitro"]. G Ital Chemioter. 1982; 29 Suppl 1:55-67. PMID: 6927122.
      View in: PubMed
    Olliaro's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description